Search results for "uva"

showing 10 items of 2916 documents

Integrating Docker to a Continuous Delivery pipeline : a pragmatic approach

2016

Docker on kevyt avoimen alustan sovellus, joka pystyy pakkaamaan sovelluksen kaikkien tarvittavien riippuvuuksien kanssa yhteen konttiin, ja tätä teknologiaa kutsutaan konttiteknologiaksi. Oikein käytettynä IT-ammattilaiset voivat saada konttiteknologiasta merkittäviä hyötyjä, sillä näitä paketteja voidaan helposti rakentaa, lähettää ja ajaa hajautetuissa järjestelmissä. Dockerin nousu on hämmästyttävää, sillä siitä on tullut konttiteknologian standardi vain kolmessa vuodessa ja se toimii jo nativisti Windowsilla sekä Linuxilla. Tämä teknologia tarjoaa suuria mahdollisuuksia tulevaisuuden ohjelmistokehitykselle sekä käyttöönotolle tarjoamalla uudenlaisia tapoja siirrettävyyden, skaalautuvuu…

Dockerkonttiteknologiavirtualisointisovelluksetjatkuva toimitussovellukset (tietotekniikka)
researchProduct

Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision

2008

OBJECTIVE: To assess whether the prescribing pattern of lipid-lowering drugs (LLD) changed after reimbursement criteria revision in a general practice in southern Italy. METHODS: From the Caserta-1 Local Health Service database, 93 general practitioners (GPs) who had consistently sent data about their patients during the years 2003-2005 were recruited. Prevalence of use and incidence of new treatments were calculated for each year, stratified by three drug cohorts: statins, omega-3 fatty acids, and fibrates. Subanalyses by gender, age, and indication of use were performed. RESULTS: Overall, 1-year prevalence of LLD use increased from 2003 to 2004. After reimbursement criteria revision (Nove…

Drug Utilizationmedicine.medical_specialtyPediatricsStatinSettore MED/09 - Medicina Internamedicine.drug_classMEDLINEstatinsInternal medicineFatty Acids Omega-3EpidemiologyHumansMedicinePharmacology (medical)RosuvastatinLipid-lowering drug Statins Omega-3 fatty acids Prevalence of use General practiceClofibrateReimbursementUnsaturated fatty acidHypolipidemic AgentsPharmacologygeneral practiceprevalence of usePrimary Health Careomega-3 fatty acidsbusiness.industryIncidence (epidemiology)General Medicinelipid-lowering drugSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheDrug UtilizationItalyInsurance Health ReimbursementSettore BIO/14 - FarmacologiaHydroxymethylglutaryl-CoA Reductase Inhibitorslipid-lowering drug; statins; omega-3 fatty acids; prevalence of use; general practicebusinessmedicine.drug
researchProduct

Could resveratrol be a useful drug for the treatment of malignant hemopathies?

2013

Resveratrol is a poly-phenol with many beneficial effects: not only as an antioxidant, anti-inflammatory, and antiatherogenic agent, as well as a platelet aggregation inhibitor, but also as an antiproliferative and proapoptotic factor in various types of cancers. There are reviews about the mechanisms responsible for its effects in leukemia and lymphomas, emphasizing the chemosensitizing role of resveratrol, which allows overcoming the multidrug resistance of cancers. The action of resveratrol occurs preferentially on leukemic cells, and not on the normal ones. In addition, it is one of the few drugs that act on leukemic stem cells. If experimental results are promising, its application in …

DrugCancer Researchmedicine.medical_treatmentmedia_common.quotation_subjectAntineoplastic AgentsPharmacologyResveratrolAntioxidantsPatents as Topicchemistry.chemical_compoundNeoplasmsDrug DiscoveryStilbenesmedicineHumansPharmacology (medical)Antiatherogenic agentmedia_commonbusiness.industryGeneral Medicinemedicine.diseaseAntineoplastic Agents PhytogenicBioavailabilityLeukemiaOncologychemistryResveratrolHematologic NeoplasmsPlatelet aggregation inhibitorDrug Therapy CombinationStem cellbusinessAdjuvantRecent patents on anti-cancer drug discovery
researchProduct

Influence of Perioperative cis-Platinum on Breaking Strength of Bowel Anastomoses in Rats

1985

Adjuvant and perioperative chemotherapy is increasingly being used in the treatment of malignant disease. Therefore, the influence of cytostatic drugs is of interest and is being investigated experimentally. The influence of various drugs is well known and has been described elsewhere (Shamberger et al. 1981). Recently, cis-platinum, an inorganic complex that inhibits DNA synthesis by cross-linking DNA strands, has been introduced. In urology it has shown a surprisingly good effect on testicular tumors and has been used in bladder cancer for palliative treatment, being one of the most potent drugs for this purpose (Yagoda 1979). It is now being combined with cystectomy for curative therapy …

DrugCisplatinmedicine.medical_specialtyBladder cancerbusiness.industrymedicine.medical_treatmentmedia_common.quotation_subjectUrologyPerioperativeAnastomosismedicine.diseaseCystectomyMedicineCombined Modality TherapybusinessAdjuvantmedia_commonmedicine.drug
researchProduct

Targeted Therapies in Hepatocellular Carcinoma

2015

Hepatocellular carcinoma (HCC) is one of the main causes of death in patients affected by chronic liver diseases. The awareness of the biomolecular mechanisms underlying the complex carcinogenic process led to the development of targeted molecules, which are able to block this process. Sorafenib is a tyrosine-kinase inhibitor, and currently, it is the only drug approved by the US Food and Drug Administration (FDA) for the treatment of HCC. However, some studies have demonstrated the efficacy of single drug therapies or combination therapies. They showed an improvement with regard to overall survival, time to progression, and progression-free survival, although these therapies were not free …

DrugOncologySorafenibmedicine.medical_specialtyCirrhosisbusiness.industrymedia_common.quotation_subjectmedicine.medical_treatmentPharmacologymedicine.diseasedigestive system diseasesFood and drug administrationLiver diseaseInternal medicineHepatocellular carcinomamedicineIn patientbusinessAdjuvantmedia_commonmedicine.drug
researchProduct

Recent progress in the pharmacotherapy of cancer pain.

2001

Cancer pain can be relatively well managed with primary therapies, according to the WHO ladder. However, different conditions may limit the response to the analgesic drug used, which are mainly oploids. Specifically, adverse effects may prevail against the analgesic activity in the clinical setting. New pharmacological strategies may enable a more satisfactory response to be obtained, in terms of balance between analgesia and adverse effects. The change of route of administration or the use of alternative opioids is a first-line option. The use of adjuvant drugs may also improve analgesia with different mechanisms. Recent studies have demonstrated the value of these alternative approaches. …

Drugmedicine.medical_specialtyAnalgesicsbusiness.industrymedicine.medical_treatmentmedia_common.quotation_subjectAnalgesicPainPain ladderRoute of administrationPharmacotherapyOncologyAnesthesiaNeoplasmsmedicineHumansPharmacology (medical)Drug InteractionsIntensive care medicineCancer painAdverse effectbusinessAdjuvantmedia_commonExpert review of anticancer therapy
researchProduct

Estudio de las alteraciones genéticas asociadas con la resistencia al tratamiento neoadjuvante de deprivación estrogénica en cáncer de mama

2021

With current standard of care adjuvant therapy, approximately 25-30% of women with high risk early stage HR+/HER2- breast cancer experience relapse. The preoperative platform offers an opportunity to interrogate mechanisms of drug resistance that, in turn, could inform the choice of adjuvant therapy. We report herein a study where we performed targeted DNA sequencing and whole transcriptome analysis on whole tumor sections from a cohort of 68 operable ER+ breast cancers treated with the aromatase inhibitor letrozole for a median of 7.2 months before surgery, and a with a median follow up of 5 years. We found that resistant tumors were enriched in clinically actionable mutation and showed an…

E2FUNESCO::CIENCIAS MÉDICAShormonoterapia neodayuvantecancer de mamaresistencia hormonal:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Web Services -tekniikoiden hyödyntäminen Java Platform, Micro Edition -ympäristössä

2008

EAIpalvelukeskeisyysWeb Servicesliikkuva tietojenkäsittelyJava Platform Micro EditionSOAintegraatioatk-ohjelmat
researchProduct

Decreased intersubject synchrony in dynamic valence ratings of sad movie contents in dysphoric individuals

2021

Emotional reactions to movies are typically similar between people. However, depressive symptoms decrease synchrony in brain responses. Less is known about the effect of depressive symptoms on intersubject synchrony in conscious stimulus-related processing. In this study, we presented amusing, sad and fearful movie clips to dysphoric individuals (those with elevated depressive symptoms) and control participants to dynamically rate the clips’ valences (positive vs. negative). We analysed both the valence ratings’ mean values and intersubject correlation (ISC). We used electrodermal activity (EDA) to complement the measurement in a separate session. There were no group differences in either t…

EXPRESSIONmasennusAdultMale515 PsychologyScienceEmotionsMotion PicturesBRAIN ACTIVITYelokuvatArticleMECHANISMSYoung Adulttoiminnallinen magneettikuvaustunteetHuman behaviourHumanskognitiivinen psykologiatarkkaavaisuusMETAANALYSISDepressionsuruQATTENTIONRBrainBIASES113 Computer and information sciencesFacial Expressionvalenssi (psykologia)negatiivisuusPATTERNSMedicineRESPONSESScientific Reports
researchProduct

Challenges of nation-branding for stimulation of Latvian exports

2017

Abstract The presented research aims to contribute to the conceptualisation of the nation-brand of Latvia with the purpose of stimulation of national export performance. The subject of the research is three aspects presumably challenging the branding of Latvia with reference to national export development. The investigated challenges are the barriers and opportunities for green-branding of Latvia; the absence of the generally accepted indication of the geographical identity of the Baltic region; and the contradictable popular image of Latvia as a cheap country. The research poses two research questions inquiring into the issues of nation-branding of Latvia currently being faced in the conte…

Economic growthHF5001-6182Economic policynationbrandingBaltic regionContext (language use)Scientific literatureExport performance03 medical and health sciences0302 clinical medicineLietuva (Lithuania)Political science0502 economics and businessAgency (sociology)Latvija (Latvia)Challenges of nation-brandingNation brandingBusinessApplied researchexport promotionHB71-74Estija (Estonia)Nacionalinis prekės ženklasnation-branding05 social scienceslatviaLatvian030206 dentistryEksportas. Importas / Export. ImportInvestment (macroeconomics)Latvialanguage.human_languageEconomics as a sciencelanguageExportNation brandingBaltijos šalys (Baltic States)challenges of nation-branding050212 sport leisure & tourism
researchProduct